• December 2012

    Sigmapharm launches, through Rising Pharmaceuticals, Inc., its 8th generic product, Griseofulvin Tablets, USP (microsize) 500 mg, which is the first-and-only approved generic equivalent to GRIFULVIN-V® Tablets.

  • November 2012

  • October 2012
    • Sigmapharm receives FDA approval for generic Griseofulvin Tablets, USP (microsize) 500 mg, based on its ANDA No. 202482.

    • Sigmapharm receives FDA approval for generic Utramicrosize Griseofulvin Tablets, USP 125 mg and 250 mg, based on its ANDA No. 202545.

  • August 2012

    Sigmapharm files an Abbreviated New Drug Application (ANDA No. 204633).